Morgan Stanley’s Cingulate CING Stock Holding History
Bought
Maintained
Sold
Other funds holding CING
VCM
KAS
XT
BAM
VFT
QC
HF
Morgan Stanley's CING Position: Q1 2026 in Review
Morgan Stanley increased its Cingulate (CING) stake by 140% in Q1 2026, buying an estimated $8.94K and bringing the position to 2,400 shares worth $14.9K. The position accounts for ﹤0.01% of the portfolio, ranked #6829.
Morgan Stanley first reported a position in CING in Q4 2025 and has held it in 2 quarters since. 27 funds tracked by Wall St. Rank hold CING as of Q1 2026.
- Morgan Stanley held 2,400 shares of Cingulate worth $14.9K as of Q1 2026.
- Morgan Stanley bought 1,400 Cingulate shares in Q1 2026, an estimated $8.94K.
- Cingulate made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #6829 holding.
- Morgan Stanley first reported a position in Cingulate in Q4 2025 and has held it in 2 quarters since.
- 27 funds tracked by Wall St. Rank held Cingulate as of Q1 2026.
Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.